As you walk into the Jennie Sealy Hospital in Galveston, it is almost as if the beach comes with you. Natural light pours into every hallway, and the floors sparkle like sand glistening in the sun. Sweeping views of Galveston Bay or the Gulf of Mexico are visible from the windows of all 310 patient rooms.
And nearly every wall in the 765,000-square-foot hospital is adorned with Galveston-themed art, bringing all the city has to offer inside for patients to enjoy.
Donna K. Sollenberger oversaw much of the building and design of the new hospital, part of The University of Texas Medical Branch at Galveston (UTMB), which opened in April.
“There are 12 principles of evidence-based design for hospitals that have been researched and found to improve the healing environment,” said Sollenberger, executive vice president and CEO of UTMB Health System. “One of those is art and another is natural light.”
Sollenberger and David L. Callender, M.D., president of UTMB, decided that the hospital should embrace and incorporate the look and feel of Galveston’s beach community.
Partnering with H. Marion Art Consultants, Inc., they created a collection of more than 1,000 pieces of art—half by artists in the Houston and Galveston areas. Because the hospital was working within a strict budget, few pieces are original. Instead, the consultants used a high-tech scanner to create copies of original works—with the artists’ approval, of course—and applied them to canvas, metal and other surfaces. Images and installations featuring sand dollars, sail boats, palm trees, photographs of the beach and Pleasure Pier are all part of the vast collection.
“One of the artists that is represented in some of the patient rooms and family areas is a retired nurse from UTMB,” Sollenberger said. “She was so honored to be part of this project and share her work with patients, staff, nurses and doctors at the Jennie Sealy Hospital.”
Employers answer the call at Mayor’s Challenge conference to help prevent suicide https://t.co/4SqzgOFWNj via #VAntagePoint
Dr. Hugo Bellen and his lab are looking into the fruit fly's genes to find the ones that cause neurodevelopment and neurodegenerative disorders. https://t.co/Q9iZDBraWs #research @BCMFomtheLabs
It was great to see some of the #ManyFacesOfUTHealth working together yesterday at the @UTHealthCIPC mass casualty simulation drill to improve their skill sets and elevate their training! https://t.co/8SD8ipgbUO #collaboration #healthcare
RT @UTCVSurgery: The @UTHealth @McGovernMed @UTCVSurgery #Vascular team at the @VascularSVS #VAM2018 interactive poster session https://t.c…
RT @UTHealthCareers: Come Join the #UTHealth Team!!!! We have openings for all positions. Click the link below and join our team!!!! https:…
VA program using telemedicine to improve care of critically ill patients in regional hospitals appeared to reduce transfers to ICUs at larger facilities without compromising patient survival, researchers said. https://t.co/3shlLvcRbn via @HealthLeaders
Today’s #VeteranOfTheDay is @USArmy Veteran Joe Lopez. https://t.co/XNJFhMYYlM
RT @RiceUNews: Thanks to @MarkBermanFox26 and all the other #Houston media for visiting campus Thursday when we introduced @RiceBaseball's…
How we’re leading the way in #thyroidcancer treatment: https://t.co/MgHQp9I0Dd #endcancer
RT @davidleebron: Here’s the sequel. Gorgeousness from the opposite perspective at the end of the day. https://t.co/TOID4qgnLF
University of Houston@UHouston
RT @UH_MVP: Come volunteer next Saturday, take some time out of your summer to give back to our Houston community! https://t.co/wIdQtK3LmX
Today @Ppisters, @svargheseCHRO and other MD Anderson senior leaders set the pace for the President’s Fitness Challenge Row, Ride, Run. Next week, all employees are invited to form teams and try to beat Dr. Pisters’ time. #endcancer https://t.co/kHPILjnwi2
RT @CaroMuriel3: “ I don’t know where I’m going from here, but I promise it won’t be boring” David Bowie💃🏻🏃🏽♀️ Running on one of the best…
@NASARocketMan Thanks for reaching out. Please send a DM so we can get more info & have management follow up ^SF
ICYMI: Phase II clinical trial offers hope for first new therapeutic option for small cell #lungcancer in more than three decades: https://t.co/kn0V96ak9v #lcsm #endcancer